Board Meeting24 Mar 2026, 05:31 pm
Natco Pharma Ltd. Approves Scheme of Arrangement, Plans Subsidiary in Nigeria, and Liquidates Australian Subsidiary
AI Summary
Natco Pharma Ltd. announced the outcomes of their recent Board Meeting. The Board approved a Scheme of Arrangement under Sections 230 to 232 of the Companies Act, 2013, to demerge the Agrochemicals Business into Natco Crop Health Sciences Limited. The company also plans to incorporate a wholly owned subsidiary in Nigeria with an investment of up to USD 100,000 and to liquidate its wholly owned subsidiary in Australia, Natco Pharma Australia Pty Ltd. The meeting also discussed other items of business.
Key Highlights
- Approval of Scheme of Arrangement for demerger of Agrochemicals Business
- Plans to incorporate a wholly owned subsidiary in Nigeria
- Decision to liquidate Natco Pharma Australia Pty Ltd.
- Disclosure of details as per Regulation 30 of the LODR Regulations